TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. financial statements, including revenue, expenses, profit, and loss

The total revenue of 600211 for the last quarter is 554.19 M CNY, and it's 37.98% lower compared to the previous quarter. The net income of Q3 24 is 168.73 M CNY.